Genotype-phenotype correlations in multiple lesions of familial cerebral cavernous malformations concerning phosphatidylinositol 3-kinase catalytic subunit alpha mutations

Jie Wang; Jihong Tang; Yingxi Yang; Yuming Jiao; Ran Huo; Hongyuan Xu; Shaozhi Zhao; Yingfan Sun; Qiheng He; Qifeng Yu; Shuo Wang; Jizong Zhao; Jiguang Wang; Yong Cao

doi:10.1002/ctm2.1610

Clinical and Translational Medicine ›› 2024, Vol. 14 ›› Issue (3) :e1610 DOI: 10.1002/ctm2.1610

LETTER TO THE JOURNAL

Genotype-phenotype correlations in multiple lesions of familial cerebral cavernous malformations concerning phosphatidylinositol 3-kinase catalytic subunit alpha mutations

Jie Wang ¹^,²
, Jihong Tang ³^,⁴
, Yingxi Yang ⁴
, Yuming Jiao ¹^,²
, Ran Huo ¹^,²
, Hongyuan Xu ¹^,²
, Shaozhi Zhao ¹^,²
, Yingfan Sun ¹^,²
, Qiheng He ¹^,²
, Qifeng Yu ¹^,²
, Shuo Wang ¹^,²
, Jizong Zhao ¹^,²
, Jiguang Wang ³^,⁴^,⁵^,^†
, Yong Cao ¹^,²^,⁶^,^†

Author information +

History +

PDF

Cite this article

Download citation ▾

Jie Wang, Jihong Tang, Yingxi Yang, Yuming Jiao, Ran Huo, Hongyuan Xu, Shaozhi Zhao, Yingfan Sun, Qiheng He, Qifeng Yu, Shuo Wang, Jizong Zhao, Jiguang Wang, Yong Cao. Genotype-phenotype correlations in multiple lesions of familial cerebral cavernous malformations concerning phosphatidylinositol 3-kinase catalytic subunit alpha mutations. Clinical and Translational Medicine, 2024, 14(3): e1610 DOI:10.1002/ctm2.1610

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Zafar A, Quadri SA, Farooqui M, et al. Familial cerebral cavernous malformations. Stroke. 2019;50:1294-1301.

[2]	Mespreuve M, Vanhoenacker F, Lemmerling M. Familial multiple cavernous malformation syndrome: MR features in this uncommon but silent threat. J Belg Soc Radiol. 2016;100:51.

[3]	Zhang J, Abou-Fadel J, Renteria M, et al. Cerebral cavernous malformations do not fall in the spectrum of pik3ca-related overgrowth. J Neurol Neurosurg Psychiatry. 2022;93(8):808-815.

[4]	Zhang J, Croft J, Le A. Familial CCM genes might not be main drivers for pathogenesis of sporadic CCMS-genetic similarity between cancers and vascular malformations. J Pers Med. 2023;13(4):673.

[5]	Huo R, Yang Y, Sun Y, et al. Endothelial hyperactivation of mutant MAP3K3 induces cerebral cavernous malformation enhanced by PIK3CA GOF mutation. Angiogenesis. 2023;26:295-312.

[6]	Hong T, Xiao X, Ren J, et al. Somatic MAP3K3 and PIK3CA mutations in sporadic cerebral and spinal cord cavernous malformations. Brain. 2021;144:2648-2658.

[7]	Scimone C, Bramanti P, Ruggeri A, et al. Detection of novel mutation in CCM3 causes familial cerebral cavernous malformations. J Mol Neurosci. 2015;57:400-403.

[8]	Donato L, Alibrandi S, Scimone C, et al. The impact of modifier genes on cone-rod dystrophy heterogeneity: an explorative familial pilot study and a hypothesis on neurotransmission impairment. PLoS One. 2022;17:e0278857.

[9]	Choi JP, Yang X, He S, et al. CCM2l (cerebral cavernous malformation 2 like) deletion aggravates cerebral cavernous malformation through MAP3K3-KLF signaling pathway. Stroke. 2021;52:1428-1436.

[10]	Garcia J, Hurwitz HI, Sandler AB, et al. Bevacizumab (avastin®) in cancer treatment: a review of 15 years of clinical experience and future outlook. Cancer Treat Rev. 2020;86:102017.

RIGHTS & PERMISSIONS

2024 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.